Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Willow Biosciences Inc T.WLLW

Alternate Symbol(s):  CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial... see more

TSX:WLLW - Post Discussion

Willow Biosciences Inc > Revenue estimates for willow
View:
Post by jermiah777 on Aug 14, 2021 3:28am

Revenue estimates for willow

I found on markets.businessinsider.com when you look up Willow under CANSF, they have an analyst that gives Willow's future revenue and EBIT ( earnings before interest and taxes) I don't know how credible it is but here are the estimates they say For 2022 17 million revenue , 5.8 million EBIT Which if true is amazing. I am following another company that is projecting 100 million revenue but only 5 million EBIT Could Willow's margins be that favorable that almost 1/3 of revenue can be EBIT ? But 2023 estimate is even more extreme. 58 million ! If true that would be revenue more than tripling from 2022 And 24 million EBIT !!! THAT would be 4 times previous year. Man if this analyst's estimates are true then we have nothing to be concerned about. Willow has 40 million in cash and their burn rate can keep them going almost 2 years. But If they get earnings of 5.8 in 2022 and 24 million in 2023 then they will not even need the whole 40 million to get to profit.
Comment by JPJune2020 on Aug 15, 2021 11:49pm
Appreciate your posts, but I do feel like WLLW's product has a hard time to sell. There are competitors out there is using the same method to make the same compound. regards of what WLLW's updates about multiple contracts. It doesn't reflect on their ERs. So they need to find buyers ASAP.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities